Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2Phase NA 1Phase 2 1

Status

Withdrawn 1Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Brain Neoplasms 1

Interventions

pembrolizumab 4Magnetic Resonance Spectroscopy 4Radiotherapy 3Nivolumab 3Cetuximab 3fluoromisonidazole 2durvalumab 2Neoadjuvant Therapy 2Metformin 2Immunohistochemistry 2Immunoglobulin G 2Fluorodeoxyglucose F18 2Cisplatin 2sitravatinib 1ruxolitinib 1ribociclib 1fluciclovine F-18 1dornase alfa 1avelumab 1antitumor A 1alovudine 1Varenicline 1Valproic Acid 1VTX-2337 1TAK-981 1Surgical Procedures, Operative 1Raltegravir Potassium 1Radiotherapy, Intensity-Modulated 1Plastic Surgery Procedures 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Squamous Cell Carcinoma of Head and Neck × fluoromisonidazole × Clear all
NCT05996432 2024-09-23

Image-Based, In-Vivo Assessment of Tumor Hypoxia to Guide Hypoxia-Driven Adaptive Radiation Therapy

Vanderbilt-Ingram Cancer Center

Phase EARLY_PHASE1 Recruiting
48 enrolled
CNSHead & Neck

Squamous Cell Carcinoma of Head and Neck, Brain Neoplasms

NCT01967927 2021-08-19

Understanding GRID Radiation Therapy Effects on Human Tumor Oxygenation and Interstitial Pressure to Increase Translation of Solid Tumor Therapy

University of Arkansas

Phase EARLY_PHASE1 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡